This is a demo store. No orders will be fulfilled.

Etaracizumab (anti-Integrin aVb3), 整合素 αVβ3 抗体

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human)
  • 亚型: Human IgG1
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175533-100μg
100μg 现货 Stock Image
Ab175533-1mg
1mg 现货 Stock Image
Ab175533-5mg
5mg 现货 Stock Image
Ab175533-10mg
10mg 期货 Stock Image

基本信息

产品名称 Etaracizumab (anti-Integrin aVb3), 整合素 αVβ3 抗体
别名 Anti-αvβ3 Integrin Recombinant Antibody | 埃达组单抗 | 伊瑞西珠 | 整合素αV(ITGaV) | 整合素β3(ITGb3) | 依他赛珠单抗(抗整合素 aVb3)
英文别名 antigen identified by monoclonal antibody L230 antibody | CD 51 antibody | CD51 antibody | DKFZp686A08142 antibody | Integrin alpha five antibody | integrin alpha V beta 3 antibody | Integrin alpha-5 antibody | integrin alpha-V antibody | Integrin alpha-V
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 Integrin aVb3 (ITGAV & ITGB3)
种属反应性 人(Human)
偶联 Unconjugated
作用类型 拮抗剂
作用机制 整合素 αVβ3 抗体

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 26.2 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 185.3 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95%
物理外观 Liquid
储存缓冲液 Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 892553-42-3
分子类型 抗体

关联靶点(人)

ITGB3 Tclin 整合素β-3(Integrin beta-3) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
ITGAV Tchem 整合素α-V(Integrin alpha-V) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
ITGAV Tchem Vitronectin receptor alpha (65 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Fibronectin receptor (Integrin alpha-5/beta-1 and alpha-V/beta-3) (39 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 and alpha-IIb/beta 3 (49 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Integrin alpha-2/beta-3 (21 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-8 (181 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGAV Tchem Integrin alpha-V/alpha-5 (6 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ITGB3 Tclin Integrin alpha-3/beta-3 (47 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Etaracizumab (anti-Integrin aVb3) (Ab175533) - Flow Cytometry
Flow Cytometry analysis of HUVEC cells labelling Integrin aVb3 (red) with Etaracizumab (anti-Integrin aVb3) (Ab175533). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Etaracizumab (anti-Integrin aVb3) (Ab175533) - SEC
The purity of Etaracizumab (anti-Integrin aVb3) (Ab175533) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ24F0303915 分析证书 Ab175533
ZJ24F0303914 分析证书 Ab175533
ZJ24F0303913 分析证书 Ab175533

引用文献

1. Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S et al..  (2006)  Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin..  Mol Cancer Ther,  (12): (3122-9).  [PMID:17172415]
2. Delbaldo C, Raymond E, Vera K, Hammershaimb L, Kaucic K, Lozahic S, Marty M, Faivre S.  (2008)  Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors..  Invest New Drugs,  26  (1): (35-43).  [PMID:17876527]
3. Felding-Habermann B, Cheresh DA.  (1993)  Vitronectin and its receptors..  Curr Opin Cell Biol,  (5): (864-8).  [PMID:7694604]

溶液计算器